{"id":"https://openalex.org/W1983075476","doi":"https://doi.org/10.1097/01.ftd.0000246763.59506.b0","title":"Effect of Adjunctive Lamotrigine Treatment on the Plasma Concentrations of Clozapine, Risperidone and Olanzapine in Patients With Schizophrenia or Bipolar Disorder","display_name":"Effect of Adjunctive Lamotrigine Treatment on the Plasma Concentrations of Clozapine, Risperidone and Olanzapine in Patients With Schizophrenia or Bipolar Disorder","publication_year":2006,"publication_date":"2006-10-01","ids":{"openalex":"https://openalex.org/W1983075476","doi":"https://doi.org/10.1097/01.ftd.0000246763.59506.b0","mag":"1983075476","pmid":"https://pubmed.ncbi.nlm.nih.gov/17038872"},"language":"en","primary_location":{"id":"doi:10.1097/01.ftd.0000246763.59506.b0","doi":"https://doi.org/10.1097/01.ftd.0000246763.59506.b0","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.ftd.0000246763.59506.b0","pdf_url":null,"source":{"id":"https://openalex.org/S179268941","display_name":"Therapeutic Drug Monitoring","issn_l":"0163-4356","issn":["0163-4356","1536-3694"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Drug Monitoring","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056735832","display_name":"Edoardo Spina","orcid":"https://orcid.org/0000-0002-2509-7449","observed_orcids":["https://orcid.org/0000-0002-2509-7449"]},"institutions":[{"id":"https://openalex.org/I112862951","display_name":"University of Messina","ror":"https://ror.org/05ctdxz19","country_code":"IT","type":"education","lineage":["https://openalex.org/I112862951"]},{"id":"https://openalex.org/I4210162269","display_name":"Centro Neurolesi Bonino Pulejo","ror":"https://ror.org/05tzq2c96","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210162269"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Edoardo Spina","raw_affiliation_strings":["Department of Clinical and Experimental Medicine and Pharmacology, Section of Pharmacology, University of Messina, Italy. espina@unime.it","IRCCS Centro Neurolesi \"Bonino-Pulejo\", Messina","Section of Pharmacology, Department of Clinical and Experimental Medicine and Pharmacology, University of Messina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical and Experimental Medicine and Pharmacology, Section of Pharmacology, University of Messina, Italy. espina@unime.it","institution_ids":["https://openalex.org/I112862951"]},{"raw_affiliation_string":"IRCCS Centro Neurolesi \"Bonino-Pulejo\", Messina","institution_ids":["https://openalex.org/I4210162269"]},{"raw_affiliation_string":"Section of Pharmacology, Department of Clinical and Experimental Medicine and Pharmacology, University of Messina","institution_ids":["https://openalex.org/I112862951"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012832535","display_name":"Concetta D\u2019Arrigo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I112862951","display_name":"University of Messina","ror":"https://ror.org/05ctdxz19","country_code":"IT","type":"education","lineage":["https://openalex.org/I112862951"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Concetta D'Arrigo","raw_affiliation_strings":["Section of Pharmacology, Department of Clinical and Experimental Medicine and Pharmacology, University of Messina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Pharmacology, Department of Clinical and Experimental Medicine and Pharmacology, University of Messina","institution_ids":["https://openalex.org/I112862951"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033211972","display_name":"Gaetana Migliardi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I112862951","display_name":"University of Messina","ror":"https://ror.org/05ctdxz19","country_code":"IT","type":"education","lineage":["https://openalex.org/I112862951"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Gaetana Migliardi","raw_affiliation_strings":["Section of Pharmacology, Department of Clinical and Experimental Medicine and Pharmacology, University of Messina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Pharmacology, Department of Clinical and Experimental Medicine and Pharmacology, University of Messina","institution_ids":["https://openalex.org/I112862951"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103745361","display_name":"Vincenza Santoro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I112862951","display_name":"University of Messina","ror":"https://ror.org/05ctdxz19","country_code":"IT","type":"education","lineage":["https://openalex.org/I112862951"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Vincenza Santoro","raw_affiliation_strings":["Section of Pharmacology, Department of Clinical and Experimental Medicine and Pharmacology, University of Messina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Pharmacology, Department of Clinical and Experimental Medicine and Pharmacology, University of Messina","institution_ids":["https://openalex.org/I112862951"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012016501","display_name":"Maria Rosaria Anna Muscatello","orcid":"https://orcid.org/0000-0001-7271-6989","observed_orcids":["https://orcid.org/0000-0001-7271-6989"]},"institutions":[{"id":"https://openalex.org/I112862951","display_name":"University of Messina","ror":"https://ror.org/05ctdxz19","country_code":"IT","type":"education","lineage":["https://openalex.org/I112862951"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Maria Rosaria Muscatello","raw_affiliation_strings":["Department of Neurosciences, Psychiatric and Anesthesiological Sciences, University of Messina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurosciences, Psychiatric and Anesthesiological Sciences, University of Messina","institution_ids":["https://openalex.org/I112862951"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045087899","display_name":"Umberto Mic\u00f2","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I112862951","display_name":"University of Messina","ror":"https://ror.org/05ctdxz19","country_code":"IT","type":"education","lineage":["https://openalex.org/I112862951"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Umberto Mic\u00f2","raw_affiliation_strings":["Department of Neurosciences, Psychiatric and Anesthesiological Sciences, University of Messina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurosciences, Psychiatric and Anesthesiological Sciences, University of Messina","institution_ids":["https://openalex.org/I112862951"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032122444","display_name":"Giuseppina D\u2019Amico","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I112862951","display_name":"University of Messina","ror":"https://ror.org/05ctdxz19","country_code":"IT","type":"education","lineage":["https://openalex.org/I112862951"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giuseppina D'Amico","raw_affiliation_strings":["Department of Neurosciences, Psychiatric and Anesthesiological Sciences, University of Messina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurosciences, Psychiatric and Anesthesiological Sciences, University of Messina","institution_ids":["https://openalex.org/I112862951"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5040883137","display_name":"Emilio Perucca","orcid":"https://orcid.org/0000-0001-8703-223X","observed_orcids":["https://orcid.org/0000-0001-8703-223X","https://orcid.org/0000-0003-3232-1389"]},"institutions":[{"id":"https://openalex.org/I25217355","display_name":"University of Pavia","ror":"https://ror.org/00s6t1f81","country_code":"IT","type":"education","lineage":["https://openalex.org/I25217355"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Emilio Perucca","raw_affiliation_strings":["Clinical Pharmacology Unit, Department of Internal Medicine and Therapeutics, University of Pavia, and Institute of Neurology IRCCS C. Mondino Foundation, Pavia, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology Unit, Department of Internal Medicine and Therapeutics, University of Pavia, and Institute of Neurology IRCCS C. Mondino Foundation, Pavia, Italy","institution_ids":["https://openalex.org/I25217355"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5012832535","https://openalex.org/A5033211972","https://openalex.org/A5056735832","https://openalex.org/A5103745361"],"corresponding_institution_ids":["https://openalex.org/I112862951","https://openalex.org/I4210162269"],"apc_list":null,"apc_paid":null,"fwci":1.2784,"has_fulltext":false,"cited_by_count":45,"citation_normalized_percentile":{"value":0.7812996,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"28","issue":"5","first_page":"599","last_page":"602"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.8871999979019165,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.8871999979019165,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.0723000019788742,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10854","display_name":"Bipolar Disorder and Treatment","score":0.016200000420212746,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lamotrigine","display_name":"lamotrigine","score":1.0},{"id":"https://openalex.org/keywords/clozapine","display_name":"clozapine","score":0.9440000057220459},{"id":"https://openalex.org/keywords/risperidone","display_name":"risperidone","score":0.9919999837875366},{"id":"https://openalex.org/keywords/olanzapine","display_name":"olanzapine","score":1.0},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.8389999866485596},{"id":"https://openalex.org/keywords/plasma-drug-concentration","display_name":"plasma drug concentration","score":0.6579999923706055},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8320000171661377},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.7369999885559082},{"id":"https://openalex.org/keywords/ugt1a4","display_name":"UGT1A4","score":0.8140000104904175},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.7670000195503235},{"id":"https://openalex.org/keywords/bipolar-disorder","display_name":"bipolar disorder","score":0.9929999709129333},{"id":"https://openalex.org/keywords/mood-stabilizers","display_name":"mood stabilizers","score":0.6859999895095825}],"concepts":[{"id":"https://openalex.org/C2778802184","wikidata":"https://www.wikidata.org/wiki/Q410346","display_name":"Lamotrigine","level":3,"score":0.9240894317626953},{"id":"https://openalex.org/C2776619155","wikidata":"https://www.wikidata.org/wiki/Q201872","display_name":"Olanzapine","level":3,"score":0.8164186477661133},{"id":"https://openalex.org/C2780057945","wikidata":"https://www.wikidata.org/wiki/Q412443","display_name":"Risperidone","level":3,"score":0.7974051237106323},{"id":"https://openalex.org/C2780864610","wikidata":"https://www.wikidata.org/wiki/Q221361","display_name":"Clozapine","level":3,"score":0.7811598181724548},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5594123005867004},{"id":"https://openalex.org/C2779253243","wikidata":"https://www.wikidata.org/wiki/Q410412","display_name":"Carbamazepine","level":3,"score":0.5228555202484131},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.46120139956474304},{"id":"https://openalex.org/C2780550438","wikidata":"https://www.wikidata.org/wiki/Q2622367","display_name":"Mood stabilizer","level":4,"score":0.45457834005355835},{"id":"https://openalex.org/C2781353949","wikidata":"https://www.wikidata.org/wiki/Q3271533","display_name":"Dopamine antagonist","level":4,"score":0.4453674554824829},{"id":"https://openalex.org/C162156334","wikidata":"https://www.wikidata.org/wiki/Q473420","display_name":"Dose","level":2,"score":0.43175381422042847},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.42611005902290344},{"id":"https://openalex.org/C2780272996","wikidata":"https://www.wikidata.org/wiki/Q1261151","display_name":"Therapeutic drug monitoring","level":3,"score":0.42597901821136475},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.42272642254829407},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.3916263282299042},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3869577646255493},{"id":"https://openalex.org/C2780948584","wikidata":"https://www.wikidata.org/wiki/Q251347","display_name":"Haloperidol","level":3,"score":0.32511448860168457},{"id":"https://openalex.org/C2776174506","wikidata":"https://www.wikidata.org/wiki/Q131755","display_name":"Bipolar disorder","level":3,"score":0.3229960799217224},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.24238333106040955},{"id":"https://openalex.org/C2778541603","wikidata":"https://www.wikidata.org/wiki/Q152763","display_name":"Lithium (medication)","level":2,"score":0.16448739171028137},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.09649452567100525},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.08122551441192627}],"mesh":[{"descriptor_ui":"D000077152","descriptor_name":"Olanzapine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077213","descriptor_name":"Lamotrigine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001714","descriptor_name":"Bipolar Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003024","descriptor_name":"Clozapine","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D003024","descriptor_name":"Clozapine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003024","descriptor_name":"Clozapine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014227","descriptor_name":"Triazines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014227","descriptor_name":"Triazines","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D014227","descriptor_name":"Triazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018967","descriptor_name":"Risperidone","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D018967","descriptor_name":"Risperidone","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018967","descriptor_name":"Risperidone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1097/01.ftd.0000246763.59506.b0","doi":"https://doi.org/10.1097/01.ftd.0000246763.59506.b0","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.ftd.0000246763.59506.b0","pdf_url":null,"source":{"id":"https://openalex.org/S179268941","display_name":"Therapeutic Drug Monitoring","issn_l":"0163-4356","issn":["0163-4356","1536-3694"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Drug Monitoring","raw_type":"journal-article"},{"id":"pmid:17038872","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17038872","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic drug monitoring","raw_type":"Clinical Trial"},{"id":"mag:2573514981","doi":null,"is_oa":false,"landing_page_url":"https://www.researchgate.net/profile/Edoardo_Spina/publication/6756386_Effect_of_Adjunctive_Lamotrigine_Treatment_on_the_Plasma_Concentrations_of_Clozapine_Risperidone_and_Olanzapine_in_Patients_With_Schizophrenia_or_Bipolar_Disorder/links/546b25c60cf2397f7830fbda.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W1964936180","https://openalex.org/W1968914386","https://openalex.org/W1970908493","https://openalex.org/W1976396370","https://openalex.org/W1976411805","https://openalex.org/W1981596120","https://openalex.org/W1991006569","https://openalex.org/W1994733841","https://openalex.org/W2003150853","https://openalex.org/W2005993886","https://openalex.org/W2013430629","https://openalex.org/W2021883998","https://openalex.org/W2025721032","https://openalex.org/W2026864077","https://openalex.org/W2039572620","https://openalex.org/W2043793079","https://openalex.org/W2044976930","https://openalex.org/W2053399522","https://openalex.org/W2073975093","https://openalex.org/W2081010551","https://openalex.org/W2085696296","https://openalex.org/W2090406820","https://openalex.org/W2092084608","https://openalex.org/W2095106622","https://openalex.org/W2098644261","https://openalex.org/W2099767837","https://openalex.org/W2114189788","https://openalex.org/W2115763439","https://openalex.org/W2122481217","https://openalex.org/W2408602005"],"related_works":["https://openalex.org/W2076385317","https://openalex.org/W2045415800","https://openalex.org/W2328148605","https://openalex.org/W2055369912","https://openalex.org/W2323465328","https://openalex.org/W119436965","https://openalex.org/W1988569883","https://openalex.org/W1989858009","https://openalex.org/W2013430629","https://openalex.org/W2093575120"],"abstract_inverted_index":{"The":[0,87,104,182],"effect":[1],"of":[2,9,58,81,90,108,175,193,201],"lamotrigine":[3,79,146],"on":[4,27],"the":[5,10,132,160,172],"steady-state":[6],"plasma":[7,88,106,173,186],"concentrations":[8,89,107],"atypical":[11],"antipsychotics":[12],"clozapine,":[13,91,176],"olanzapine,":[14],"and":[15,64,71,76,83,94,124,137,178],"risperidone":[16,37],"was":[17,51,148],"investigated":[18],"in":[19,151,185],"patients":[20],"with":[21,30,102],"schizophrenia":[22],"or":[23,43],"bipolar":[24],"disorder":[25],"stabilized":[26],"chronic":[28],"treatment":[29,73,101],"clozapine":[31],"(200-500":[32],"mg/day;":[33,39,46],"n":[34,40,47],"=":[35,41,48],"11),":[36],"(3-6":[38],"10)":[42],"olanzapine":[44,109,187,195],"(10-20":[45],"14)).":[49],"Lamotrigine":[50],"titrated":[52],"up":[53],"to":[54,191,199],"a":[55,166],"final":[56],"dosage":[57],"200":[59,84],"mg/day":[60,85],"over":[61],"8":[62],"weeks,":[63],"pharmacokinetic":[65],"assessments":[66],"were":[67,110],"made":[68],"at":[69,78,115,121,129,159],"baseline":[70,138],"during":[72,100],"weeks":[74],"6":[75],"10,":[77,131],"dosages":[80,161],"100":[82],"respectively.":[86],"norclozapine,":[92],"risperidone,":[93,177],"9-hydroxy-risperidone":[95],"did":[96],"not":[97,170],"change":[98],"significantly":[99],"lamotrigine.":[103],"mean":[105],"31":[111],"+/-":[112,118,126],"7":[113,119],"ng/mL":[114,120,128],"baseline,":[116],"32":[117],"week":[122,130,135],"6,":[123],"36":[125],"9":[127],"difference":[133],"between":[134],"10":[136],"being":[139],"statistically":[140],"significant":[141],"(P":[142],"<":[143],"0.05).":[144],"Adjunctive":[145],"therapy":[147],"well":[149],"tolerated":[150],"all":[152],"groups.":[153],"These":[154],"findings":[155],"indicate":[156],"that":[157],"lamotrigine,":[158],"recommended":[162],"for":[163],"use":[164],"as":[165],"mood":[167],"stabilizer,":[168],"does":[169],"affect":[171],"levels":[174],"their":[179],"active":[180],"metabolites.":[181],"modest":[183],"elevation":[184],"concentration,":[188],"possibly":[189],"due":[190],"inhibition":[192],"UGT1A4-mediated":[194],"glucuronidation,":[196],"is":[197],"unlikely":[198],"be":[200],"clinical":[202],"significance.":[203]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":5},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}